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Abstract
Background: Whereas it is well established that plasma lipid levels have substantial heritability within populations, it
remains unclear how many of the genetic determinants reported in previous studies (largely performed in European
American cohorts) are relevant in different ethnicities.
Methodology/Principal Findings: We tested a set of ,50,000 polymorphisms from ,2,000 candidate genes and genetic
loci from genome-wide association studies (GWAS) for association with low-density lipoprotein cholesterol (LDL-C), high-
density lipoprotein cholesterol (HDL-C), and triglycerides (TG) in 25,000 European Americans and 9,000 African Americans in
the National Heart, Lung, and Blood Institute (NHLBI) Candidate Gene Association Resource (CARe). We replicated
associations for a number of genes in one or both ethnicities and identified a novel lipid-associated variant in a locus
harboring ICAM1. We compared the architecture of genetic loci associated with lipids in both African Americans and
European Americans and found that the same genes were relevant across ethnic groups but the specific associated variants
at each gene often differed.
Conclusions/Significance: We identify or provide further evidence for a number of genetic determinants of plasma lipid
levels through population association studies. In many loci the determinants appear to differ substantially between African
Americans and European Americans.
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Introduction
Plasma concentrations of lipids and lipoproteins [low-density
lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol
(HDL-C), triglycerides (TG)] are heritable risk factors for
cardiovascular disease [1,2]. Recently, genome-wide association
mapping of common variants (.5% minor allele frequency) in
individuals of European ancestry has proven useful in identifying
genetic loci contributing to plasma lipids [3]. Roughly one third of
these loci harbor genes with previously recognized involvement in
lipid metabolism, many by virtue of having rare variants that result
in Mendelian disorders. The other loci are suspected to harbor
novel lipid regulators, the study of which has the potential of
providing important new insights into lipid biology.
As promising as these observations may be, several critical
questions remain – How many of the previously reported loci are
genuine causal determinants of plasma lipid levels? Are there more
loci associated with plasma lipids that are discoverable with
techniques besides genome-wide association mapping? Do any of
these loci confer effects on lipids in an ethnic-specific manner? To
address these questions, we utilized the National Heart, Lung, and
Blood Institute (NHLBI) Candidate Gene Association Resource
(CARe) comprising more than 40,000 individuals from nine
prospective cohorts with measured lipid phenotypes and genotype
information obtained using the ‘‘ITMAT-Broad-CARe’’ array, or
IBC array, with ,50,000 polymorphisms from ,2,000 candidate
genes/loci [4,5]. Most of the polymorphisms on this array were
obtained from a systematic literature search for candidate genes
implicated in cardiovascular diseases; these were supplemented
with polymorphisms from loci identified in early genome-wide
association studies (GWAS) for lipids [5].
We initiated this study with specific hypotheses: (1) Common
DNA sequence variants in previously reported genes and loci, as
well as additional novel loci, are associated with plasma lipids; (2)
At some of these loci, the specific variants related to plasma lipids
differ between ethnic groups. To test these hypotheses, we
performed association analyses of the polymorphisms on the
IBC array in 25,000 European Americans and 9,000 African
Americans in CARe.
Materials and Methods
Ethics Statement
All participants in each of the CARe cohorts gave informed
written consent. The Institutional Review Boards (IRBs) of each
CARe cohort (i.e., the IRBs for each cohort’s field centers,
coordinating center, and laboratory center) have reviewed and
approved the cohort’s interaction with CARe. The study described
in this manuscript was approved by the Committee on the Use of
Humans as Experimental Subjects (COUHES) of the Massachu-
setts Institute of Technology.
CARe Study Design and Quality Control
A full description of the CARe Study is found elsewhere [4]. In
brief, DNA samples and phenotypic information from nine
NHLBI prospective cohorts [the Atherosclerosis Risk In Commu-
nities (ARIC) study, the Coronary Artery Risk Development In
Young Adults (CARDIA) study, the Cleveland Family Study
(CFS), the Cardiovascular Health Study (CHS), the Cooperative
Study of Sickle Cell Disease (CSSCD), the Framingham Heart
Study (FHS), the Jackson Heart Study (JHS), the Multi-Ethnic
Study of Atherosclerosis (MESA), and the Sleep Heart Health
Study (SHHS)] were assembled at the Broad Institute of MIT and
Harvard. We used the following strata of cohort and ethnicity
(EA=European American, AA=African American): ARIC-AA,
CARDIA-AA, CFS-AA, CHS-AA, JHS, MESA-AA, ARIC-EA,
CARDIA-EA, CFS-EA, CHS-EA, FHS, MESA-EA. Plasma lipid
levels–LDL-C, HDL-C, TG–from the baseline examinations of
cohort participants were used (Table S1). All phenotypes,
including plasma lipid levels, had been standardized according
to the Clinical Data Interchange Standard Consortium Study
Data Tabulation Model (CDISC SDTM).
All DNA samples passing initial quality checks were interrogat-
ed with the IBC v2 chip for genotyping of 49,320 total single
nucleotide polymorphisms (SNPs). Samples with overall genotyp-
ing success rate ,95%, individual SNPs with genotyping success
rate ,95% within a cohort, monomorphic SNPs, and SNPs
mapping to multiple genomic loci were removed. An inbreeding
coefficient was calculated for each sample as a measure of
heterozygosity, with those samples exceeding 4 standard deviations
from the mean (suggesting poor DNA quality if too low, or sample
contamination if too high) being removed. In cases of identical
DNA samples, the sample with the lowest genotyping success rate
was removed. Samples that shared 5% or more of their genome
with many other samples were also removed. Additional outlier
samples as determined by multidimensional scaling were also
removed. SNPs for which genotype missingness could be predicted
by surrounding haplotypes were removed, as were any SNPs
found to be associated with chemistry plates. Pedigrees and SNPs
not conforming to Mendelian expectations were identified and,
where appropriate, samples were removed. These analyses were all
performed with PLINK [6].
Because different ethnic groups were represented, with the
expectation of differing genotype frequencies and admixture, no
filters were applied for minor allele frequency or Hardy-Weinberg
P values. The Hardy-Weinberg P value for each index SNP in
each cohort is listed in Table S2.
About 2,000 ancestry-informative markers were included in the
IBC v2 chip [4]. ANCESTRYMAP [7] was used to generate
estimates for global ancestry in African American samples.
EIGENSTRAT [8] was used for self-reported African Americans
and European Americans separately to generate ten principal
components each accounting for population stratification. We
Multi-Ethnic Lipid Loci in CARe
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e36473found that the first principal component for African Americans
was highly correlated with the global ancestry estimates (r
2.0.98).
Phenotype Modeling
We modeled the lipid phenotypes in the following ways. LDL-C
was calculated according to Friedewald’s formula: LDL-C=total
cholesterol – HDL-C – (TG 4 5). If a TG value was .400 mg/
dL, LDL-C was treated as a missing value. For individuals on
lipid-lowering therapy, the LDL-C value was multiplied by 1.42 to
model a 30% reduction in LDL-C on therapy. This represents the
average expected reduction in LDL-C with a first-generation
statin, the most commonly used lipid-lowering medication during
the study periods of most of the cohorts [9]. TG values were
log(10)-transformed. Sex-specific phenotype residuals were con-
structed within strata of cohort and ethnicity after accounting for
age and age
2. Each set of residuals was standardized to a mean of
zero and a standard deviation of one. The standardized residual
served as the phenotype in genotype-phenotype association
analyses. Generation of residuals was performed with the R
statistical package (The R Foundation for Statistical Computing,
Vienna, Austria).
Association Testing
For each of the three traits, we used linear regression to test
SNP-phenotype associations in each stratum of cohort and
ethnicity assuming an additive genetic model, using the ten
calculated principal components as covariates: phenotype ,
genotype + PC1+ PC2+ PC3+ PC4+ PC5+ PC6+ PC7+ PC8+
PC9+ PC10. These association analyses were performed in
PLINK. Genotype-phenotype associations within each ethnic
group were assessed by weighted z-score-based fixed-effects meta-
analysis and effect size estimates (b values) generated by inverse-
variance weighted meta-analysis, both using METAL (G.
Abecasis, University of Michigan). Genomic control correction
was applied to each cohort individually prior to meta-analysis, and
a final genomic control correction was applied to each ethnicity’s
meta-analysis dataset. For all cross-ethnic comparisons, only SNPs
available in all cohorts (12 total) were considered. We considered
P=1 610
26 to be the threshold for statistical significance, applying
a Bonferonni correction for the number of SNPs tested (0.05 4
50,000).
We performed sensitivity analyses for two cohorts for which
there were significant numbers of related individuals–CFS and
FHS–to account for family relationships, using a linear mixed
effects (LME) model to analyze the lipid residuals, with the SNP
genotype treated as a fixed effect, and a random effect according
to the degree of relatedness within a family [10]. Upon substitution
of these data into the meta-analyses for each lipid trait, there were
essentially no differences in the SNPs found to be statistically
significant, and these data were not considered further.
To identify SNPs exerting sex-specific effects, we added sex as a
covariate in the above linear regression model and tested for a
formal SNP6sex interaction; the results were meta-analyzed as
described above. Similarly, to test for SNP6SNP interactions
among the most strongly associated SNPs at each of the identified
loci, we added the minor allele count for each SNP as a covariate,
in turn, into the above model (with sex removed), testing for a
formal interaction between each SNP pair combination.
For those loci containing IBC-significant SNPs in both
ethnicities, we performed SNP conditional analyses. These were
conducted by adding SNP allele counts as extra covariates to the
initial linear regression model described above. The conditional
analyses were performed iteratively, with additional independent
SNPs identified at each step in each locus added to the model.
Adjusted R
2 values for each SNP included in the conditional
analyses, as well as for the combination of independently
significant SNPs at each locus, were calculated by replicating the
relevant linear regression model in the largest cohort (ARIC for
both ethnicities) using Statistics Package for Social Sciences (SPSS)
software (version 16.0; SPSS Inc., Chicago, IL), with principal
components excluded.
Results
Replication of Reported Lipid-associated Loci and
Identification of New Loci
Nineteen lipid-associated loci that were reported in an early set
of lipid GWAS studies of individuals of European ancestry were
included in the IBC v2 array–these loci harbor the genes SORT1,
CILP2/PBX4, GALNT2, MLXIPL, TRIB1, ANGPTL3, APOB,
APOE, HMGCR, LDLR, PCSK9, ABCA1, APOA1/APOA5, CETP,
LIPC, LIPG, LPL, GCKR, and MVK-MMAB [11–14]. We found
that SNPs at all 19 loci replicated in the CARe European
American cohorts (Table 1) at the pre-specified IBC significance
level (P,1610
26). Importantly, there was no overlap between the
GWAS cohorts and the CARe cohorts. We also found that SNPs
at 10 loci replicated in the CARe African American cohorts–
SORT1 (sortilin), APOB (apolipoprotein B), APOE (apolipoprotein
E), LDLR (LDL receptor), PCSK9 (proprotein convertase subtili-
sin/kexin type 9), ABCA1 [ATP-binding cassette, sub-family A
(ABC1), member 1], APOA1 (apolipoprotein A-I), CETP, (choles-
teryl ester transfer protein), LIPC (hepatic lipase), and LPL
(lipoprotein lipase) (Table 1). All of these genes, with the exception
of SORT1, have well-described functions in lipoprotein metabo-
lism.
We also found significant associations for a number of IBC
SNPs chosen for their proximity to candidate genes selected from
the literature. Of these, eight loci–FADS1 (fatty acid desaturase 1),
PLTP (phospholipid transfer protein), LCAT (lecithin-cholesterol
acyltransferase), ANGPTL4 (angiopoietin-like 4), ABCG5/ABCG8
(ATP-binding cassette sub-family G members 5 and 8; sterolin-1
and -2), LPA [lipoprotein(a)], NPC1L1 [NPC1 (Niemann-Pick
disease, type C1, gene)-like 1], HPR (haptoglobin-related protein)–
were shown to have genome-wide-significant lipid-associated SNP
variants in GWAS reported subsequent to the fabrication of the
IBC array (Table 1) [3]. All of these genes, with the exception of
FADS1 and HPR, have well-described functions in lipoprotein
metabolism. The LCAT locus was notable for being IBC-
significant for HDL-C in both CARe European Americans and
African Americans. An additional significant locus in African
Americans harboring CD36 (cluster of differentiation 36; throm-
bospondin receptor) had previously been reported in a candidate
gene study; indeed, the same SNP that was IBC-significant
(rs3211938) was shown in that prior study to be a nonsense coding
variant that resulted in CD36 deficiency in a homozygous
individual and was associated with increased HDL-C levels
(P=0.00018) and decreased TG levels (P=0.0059) in an African
American cohort [15].
Finally, one locus harbors an IBC-significant variant that has
not previously been reported to be associated with lipid traits–
ICAM1 (intercellular adhesion molecule 1) in CARe African
Americans (Table 1). Of note, the P value of association
(1.24610
28) for the ICAM1 SNP rs5030359 is not only IBC-
significant but also genome-wide-significant. This variant is of low
frequency in African Americans (just under 1%) and is virtually
absent in European Americans. Interestingly, this variant demon-
strated the largest effect size for any trait + ethnicity combination
(b=–0.52).
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to European Americans
Comparing each index SNP in each of the lipid loci in
European Americans to African Americans, we noted quite varied
patterns of association. In some cases, the effect size estimates and
minor allele frequencies (MAFs) are quite similar in two ethnicities.
An example is SNP rs6511720 in the LDLR locus, with b=–0.23
(in standard deviation units) and MAF=0.12 in European
Americans, b=–0.20 and MAF=0.14 in African Americans for
LDL-C (Table 1). The relative P values (P=1.38610
249 vs.
P=1.75610
218) can be attributed solely to the different sample
sizes (25,000 European Americans vs. 9,000 African Americans).
Another example is rs1748197 in the ANGPTL3 (angiopoietin-like
3) locus, which has b=–0.053 and MAF=0.34 in European
Americans, b=–0.042 and MAF=0.34 in African Americans for
TG (P=6.23610
27 vs. P=0.012).
Other index SNPs diverged considerably in the two ethnicities.
Some of the SNPs displayed considerable differences in their
estimated effect sizes despite similar MAFs. Notable examples
include rs2278236 in the ANGPTL4 locus, with b=0.048
(MAF=0.48; P=6.46610
27) in European Americans and b=–
0.00060 (MAF=0.48; P=0.96) in African Americans; rs4846918
in the GALNT2 (UDP-N-acetyl-alpha-D-galactosamine:polypep-
tide N-acetylgalactosaminyltransferase 2) locus, with b=0.069
(MAF=0.15; P=4.22610
27) in European Americans and
b=0.016 (MAF=0.14; P=0.45) in African Americans for
HDL-C; and rs2515629 in the ABCA1 locus, with b=0.0079
(MAF=0.17; P=0.53) in European Americans and b=0.11
(MAF=0.17; P=2.04610
27) in African Americans for HDL-C.
These findings indicate considerable heterogeneity in the archi-
tecture of lipid-related loci in the two ethnicities.
We took advantage of the dense genotyping in each locus on the
IBC v2 array to perform more detailed comparisons of the 11 loci
that harbored IBC-significant SNPs for both ethnicities (Table 2).
In only two of the loci (LIPC for HDL-C, LDLR for LDL-C) was
the same SNP the most highly associated for the trait in each
ethnicity. At an additional four loci (SORT1 with LDL-C, APOB
with LDL-C, LPL with HDL-C and TG, LCAT with HDL), the
most highly associated SNP in one ethnicity was among the most
highly associated SNPs in the other ethnicities. In the remaining
five loci (PCSK9 for LDL-C, ABCA1 for HDL-C, APOA1-C3-A4-A5
for TG, CETP for HDL, APOE for LDL-C and TG), the most
highly associated SNPs in the ethnicities did not overlap.
For each ethnicity we performed conditional analyses with the
most highly associated SNPs in each of the 11 loci to uncover any
additional, independently associated SNPs (at IBC significance) in
the same gene regions (Table 2). We performed this iteratively
until no association signals remained in each locus. By this
criterion, we identified up to four independent SNP variants (in
the case of CETP with HDL-C in European Americans) per locus.
Remarkably, only one locus (SORT1) harbored a single indepen-
dent SNP in each ethnic group.
For many gene regions, the independent SNPs did not
colocalize in the two ethnicities. For example, in the PCSK9 locus,
the most highly associated SNPs (rs11591147 in European
Americans and rs11806638 in African Americans) are more than
10 kb apart and show much weaker associations (and are much
less common) in the other ethnicity (Table 2). Similarly, the second
independent SNPs (rs499883 in European Americans and
rs505151 in African Americans) are more than 10 kb apart and
are each absent in the other ethnicity. Similar patterns are seen
with APOB, APOA1-C3-A4-A5, and LCAT. More complex patterns
are seen in loci such as LPL, CETP, and APOE, where some
independent SNPs colocalize (within a few kb of each other) and
others are distant.
Notably, for two loci/trait combinations–LCAT with HDL,
APOE with TG–the strength of association of SNPs is greater in
African Americans than in European Americans (Table 2). For
APOE, this is due to the rarity of the index SNP (rs12721054) in
European Americans (MAF=0.00047 vs. MAF=0.12), since the
effect size estimates are similar in the two ethnic groups (b=0.33
in European Americans vs. b=0.26 in African Americans). For
LCAT, rarity accounts for the second independent SNP in African
Americans (rs35673026, absent in European Americans) but not
the most highly associated SNP (rs255052, similarly common in
European Americans, MAF=0.15 vs. MAF=0.22, with modestly
different effect size estimates, b=0.069 vs. b=0.11). No second
independent SNP for LCAT was identified in European Ameri-
cans.
Table 2 also reports the proportion of the variance (adjusted R
2)
in the respective traits explained by each SNP and the
combination of the independently significant SNPs at each locus.
The greatest proportion of variance explained by a single SNP in
African Americans was 3.7% (rs17231520 for HDL-C); for
European Americans it was 2.5% (rs17231506 for HDL-C).
These SNPs are both located in the CETP locus on chromosome
16. Unsurprisingly, the CETP locus explained the greatest
proportion of variance, in any trait, for both African Americans
and European Americans (explaining 5.0% and 3.6% of the
variance in HDL-C, respectively). For African Americans, the
combination of all independently significant SNPs at the 11 loci
that harbored IBC-significant SNPs for both ethnicities explained
4.5%, 7.7%, and 1.9% of the variance in LDL-C, HDL-C, and
TG, respectively. For European Americans, 6.2%, 6.0%, and
4.1% of the variance in LDL-C, HDL-C, and TG were explained,
respectively.
SNP6SNP Interactions and SNPs Exerting Sex-specific
Effects
We investigated whether any SNP6SNP interactions existed
between any of the most significant SNPs identified at each of the
19 above-mentioned loci for their respective traits; none were
identified (Tables S3, S4, S5, S6, S7, S8). The lowest P value
(0.002) was generated for the interaction between SNPs
rs10455872 (LPA) and rs934197 (APOB) for LDL-C in African
Americans, but was far from IBC-significant and withstands a
Bonferroni correction of only 25 tests (there were 120 SNP6SNP
interactions tested for LDL-C among African Americans).
Similarly, no IBC-significant SNP6sex interactions were
observed among the SNPs identified in Table 1 (Tables S9, S10,
S11). Of note, the SNP rs4810479 (PLTP) generated a P value of
1.51610
24 for HDL-C among European Americans and was
highly significant among women (P=7.11610
212) but not men
(P=0.12). The P value of this interaction was two orders of
magnitude smaller than for any of the other SNPs for any lipid
trait, with the exception of rs439401 (P=1.30610
23 for TG
among European Americans). Expanding the search to all SNPs
on the IBC chip failed to identify any further IBC-significant
SNP6sex interactions (Tables S12, S13).
Discussion
In this work, we identify or provide further evidence for a
number of genetic determinants of plasma lipid levels through
population association studies of two ethnicities. Specifically, the
results of these studies support each of our hypotheses.
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Genes and Loci, as well as Additional Novel Loci, are
Associated with Plasma Lipids
We found that all 19 lipid-associated loci identified in early
GWAS studies replicated in the combined CARe European
American cohorts (,25,000 individuals), and 10 of the loci
replicated in the combined CARe African American cohorts
(,9,000 individuals). It is likely that with genotyping in additional
African American individuals, increased power will ultimately
allow replication of many of the remaining nine loci. We identified
an additional 10 loci associated with one or more lipid traits at
Bonferroni-corrected statistical significance. Eight of these loci
were mapped in GWAS studies subsequent to the design of the
IBC array, and one locus had been identified in a prior non-
GWAS study. The remaining locus, ICAM1, is novel. The
identification of ICAM1 is of particular interest because its
association with LDL-C was exclusive to African Americans.
These findings give a high degree of confidence that most, if not
all, of the reported GWAS lipid loci harbor authentic determinants
of plasma lipid levels deserving of further functional investigation,
and that many of the loci are relevant not just in European
American populations but more generally in global populations.
At Some Lipid-associated Loci, the Specific Variants
Related to Plasma Lipids Differ between Ethnic Groups
We were able to use the dense SNP genotyping in loci available
via the IBC array to analyze lipid-associated loci in an
unprecedented level of detail, particularly in African Americans.
Our analyses demonstrate that at many loci there are major
differences in genetic architecture between European Americans
and African Americans. These differences manifest in at least three
ways.
First, some of the most highly associated SNPs in one ethnicity
are rare or absent in the other ethnicity. This is a well-established
phenomenon; for example, truncation mutations in PCSK9 that
are of low frequency in African Americans, but absent in
European Americans, have been shown to result in a robust
reduction in LDL-C levels and coronary heart disease risk [16,17].
Many of the discrepancies in lipid associations of SNPs between
the two ethnicities can be attributed primarily to differences in
allele frequency. For example, rs3211938 in CD36 is much more
highly associated with HDL-C in African Americans
(P=2.60610
212) than in European Americans (P=0.030), with
a large discrepancy in MAFs (8.3% vs. 0.01%) (Table 1). Similarly,
rs12721054 in APOE is both more highly associated with TG and
more frequent in African Americans (P=5.55610
225,
MAF=12%) than in European Americans (P=0.60,
MAF=0.047%). These variants may represent causal variants,
as is the case with the nonsense coding variant rs3211938 in CD36
[15].
Second, some of the most highly associated SNPs in one
ethnicity are poorly associated in the other ethnicity despite similar
MAFs in both groups. An example is rs2515629 in the ABCA1
locus (P=2.04610
27, MAF=0.17, b=0.11 in African Ameri-
cans; P=0.53, MAF=0.17, b=0.0079 in European Americans)
(Table 2). In cases like this, it seems unlikely that the SNP
represents a causal variant that acts exclusively in one ethnic
group. Instead, rs2515629 is likely to be in strong linkage
disequilibrium with an unrecognized (not genotyped on the IBC
array) causal variant in African Americans; this causal variant may
not be present in European Americans, or it may be present but in
poor linkage disequilibrium with rs2515629 in European Amer-
icans due to differences in correlation structure.
Third, in some gene regions there are differences in the
distributions of independent lipid-associated SNPs. Presumably
these independent SNPs reflect the presence of independent causal
variants. For example, in the CETP locus we identified at least 3
independently associated SNPs (with HDL) in African Americans
and 4 independently associated SNPs in European Americans
(Table 2), scattered over a range of 20 kb, with none clearly
marking the same causal variants. Similar complexity is seen in the
PCSK9, LPL, and APOE loci and, to a lesser degree, in most of the
other 11 loci for which we performed conditional analyses (Figures
S1 and S2). Thus, significant variability in the full spectrum of
causal DNA variants across gene regions in different ethnic groups
may well be the rule rather than the exception.
A previous analysis of lipid-associated loci in the Jackson Heart
Study identified several loci–LPL, APOB, and GCKR–that appeared
to account for some part of the inter-ethnic variation in lipid
profiles, and found that SNPs in the LPL locus displayed different
effect sizes depending on whether they existed on a background of
European vs. African ancestry [18]. Our study found evidence of a
similar phenomenon for a larger number of loci. In the LPL locus,
for example, the most highly associated SNPs for TG in either
European Americans and African Americans both have larger
estimated effect sizes in the latter than the former (rs3916027,
b=–0.089 vs. b=–0.0072; rs327, b=0.097 vs. b=0.0026),
consistent with what was observed in the previous study. Other
loci in which specific variants appear to have larger effect sizes in
African Americans than in European Americans include PCSK9
for LDL-C (rs11806638, b=–0.11 vs. b=–0.054), GCKR for TG
(rs1260326, b=0.088 vs. b=0.037), APOA1-C3-A4-A5 for TG
(rs2075290, b=–0.12 vs. b=–0.064; rs9804646, b=–0.083 vs.
b=–0.039), and LCAT for HDL-C (b=0.11 vs. b=0.069), among
others. Similarly, there are a number of loci in which specific
variants appear to have larger effect sizes in European Americans
than in African Americans (Table 1). Thus, genetic differences in
lipid determinants between the two ethnicities appear to be
widespread across many loci.
Inter-ethnic Comparisons of SNP-phenotype
Relationships may Pinpoint Causal DNA Variants
Finally, while it has been assumed that differing patterns of
linkage disequilibrium in European Americans and African
Americans could be helpful in localizing shared, causal DNA
variants, for the reasons stated above this may not often be the
case. Of the 29 loci we studied, only in 4 cases did association
signals in the two ethnicities appear to unambiguously converge
(Figures S1 and S2).
In the SORT1 locus, the most highly associated SNPs in the two
ethnicities were not identical but were in close proximity (within a
few kb) and in high linkage disequilibrium, suggesting that they are
marking the same causal variant (Figure S1A). In European
Americans, we found six SNPs that together bear the strongest
association with LDL-C (P values ranging from 1.69610
251 to
1.33610
249) and are effectively in perfect linkage disequilibrium.
In contrast, for the same 6 SNPs in African Americans, they are in
varying degrees of linkage disequilibrium, with rs12740374
standing out as having the strongest association (P=9.33610
220
in African Americans; P=2.90610
251 in European Americans).
Thus, this analysis nominates rs12740374 as a strong candidate for
the causal variant in the locus. Of note, a recent study identified
rs12740374 as a causal variant through functional experimenta-
tion in cell-based reporter assays [19], confirming the potential
value of inter-ethnic comparisons of SNP-phenotype relationships
in identifying causal DNA variants.
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rs2070895 were the most highly associated SNPs in both
ethnicities, suggesting that each is either a causal SNP or tightly
linked to a causal SNP (Figure S1B, S1C). In the APOB locus, the
most highly LDL-C-associated SNP in European Americans,
rs934197, is not associated with LDL-C in African Americans
despite being common in the second ethnic group (Figure S1D).
However, the second independent SNP in the locus found in
European Americans, rs562338, is the most highly LDL-C-
associated SNP in African Americans, suggesting that it may be a
causal variant in the APOB locus, albeit not the only one detected
in European Americans.
Rs6511720 is located in intron 1 of the LDLR gene, suggesting
that it might affect either transcription or splicing of the gene
transcript. Rs2070895 is in the promoter region of LIPC, just
300 bp upstream of the start codon, suggesting a role in gene
transcription. Finally, rs562338 is located 20 kb upstream of the
APOB gene, which would suggest some long-range regulatory role.
Further experimentation aimed at evaluating whether rs6511720,
rs2070895, and rs562338 are indeed causal DNA variants and by
what mechanisms they might act in their respective loci is
warranted.
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